We are live on
!
Find out more
EOJOAM
E. Ohman J:or Asset Management Portfolio holdings
AUM
$4.3B
1-Year Est. Return
29.55%
This Fund
S&P 500
This Quarter
Est. Return
+22.53%
1 Year Est. Return
+29.55%
3 Year Est. Return
+110.24%
5 Year Est. Return
+144.75%
10 Year Est. Return
+695.34%
AUM
$4.3B
AUM Growth
+$519M
(+14%)
Cap. Flow
-$26.3M
Cap. Flow
% of AUM
-0.61%
Top 10 Holdings %
Top 10 Hldgs %
43.48%
Holding
487
New
10
Increased
143
Reduced
81
Closed
22
Top Buys
| 1 |
Eli Lilly
LLY
|
+$38.6M |
| 2 |
Stryker
SYK
|
+$37.7M |
| 3 |
Capital One
COF
|
+$33.6M |
| 4 |
Dover
DOV
|
+$31M |
| 5 |
RadNet
RDNT
|
+$23.4M |
Top Sells
| 1 |
Cboe Global Markets
CBOE
|
+$56.7M |
| 2 |
Gilead Sciences
GILD
|
+$44.4M |
| 3 |
AT&T
T
|
+$34.8M |
| 4 |
Intuit
INTU
|
+$32.5M |
| 5 |
Boston Scientific
BSX
|
+$29.4M |
Sector Composition
| 1 | Technology | 43.83% |
| 2 | Financials | 13.15% |
| 3 | Healthcare | 10.01% |
| 4 | Communication Services | 9.79% |
| 5 | Consumer Discretionary | 8.15% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
101
Lowe's Companies
LOW
$116B
| $4.86M | 0.11% |
22,027
| – | – |
|
102
Pfizer
PFE
$138B
| $4.79M | 0.11% |
199,117
| – | – |
|
103
Cadence Design Systems
CDNS
$104B
| $4.72M | 0.11% |
12,576
+450
| +4% | +$158K |
|
104
TJX Companies
TJX
$166B
| $4.65M | 0.11% |
30,680
-13,050
| -30% | -$2.06M |
|
105
Dell
DELL
$296B
| $4.44M | 0.1% |
10,300
-500
| -5% | -$145K |
|
106
Vertex Pharmaceuticals
VRTX
$121B
| $4.38M | 0.1% |
8,823
| – | – |
|
107
Applovin
APP
$151B
| $4.3M | 0.1% |
8,341
+2,750
| +49% | +$1.33M |
|
108
Danaher
DHR
$141B
| $4.24M | 0.1% |
22,273
| – | – |
|
109
Denali Therapeutics
DNLI
$3.59B
| $4.12M | 0.1% |
+160,000
| New | +$3.29M |
|
110
Lantheus
LNTH
$6.66B
| $4.1M | 0.1% |
36,937
| – | – |
|
111
Cirrus Logic
CRUS
$6.93B
| $4.09M | 0.1% |
27,553
+1,341
| +5% | +$219K |
|
112
S&P Global
SPGI
$130B
| $4.04M | 0.09% |
10,476
-3,300
| -24% | -$1.39M |
|
113
Live Oak Bancshares
LOB
$1.92B
| $4.03M | 0.09% |
98,745
| – | – |
|
114
Bristol-Myers Squibb
BMY
$116B
| $4.01M | 0.09% |
69,612
| – | – |
|
115
Repligen
RGEN
$8.3B
| $3.9M | 0.09% |
28,600
| – | – |
|
116
Comcast
CMCSA
$82.8B
| $3.86M | 0.09% |
157,351
+3,000
| +2% | +$77.4K |
|
|
SCHW
117
Charles Schwab
SCHW
$176B
| $3.85M | 0.09% |
41,700
+2,000
| +5% | +$182K |
|
118
Howmet Aerospace
HWM
$111B
| $3.8M | 0.09% |
14,152
+1,500
| +12% | +$385K |
|
119
Ocular Therapeutix
OCUL
$2.12B
| $3.78M | 0.09% |
385,000
+85,000
| +28% | +$770K |
|
120
CAVA Group
CAVA
$8.15B
| $3.72M | 0.09% |
47,370
+6,281
| +15% | +$527K |
|
121
Futu Holdings
FUTU
$13.8B
| $3.69M | 0.09% |
39,400
+36,000
| +1,059% | +$4.61M |
|
122
Starbucks
SBUX
$121B
| $3.69M | 0.09% |
36,114
+5,400
| +18% | +$544K |
|
123
Vera Therapeutics
VERA
$3.1B
| $3.68M | 0.09% |
85,777
+42,787
| +100% | +$1.59M |
|
124
Quanta Services
PWR
$99.2B
| $3.65M | 0.08% |
5,070
| – | – |
|
125
Installed Building Products
IBP
$6.05B
| $3.61M | 0.08% |
15,711
+3,365
| +27% | +$818K |
|
Similar funds
CW
PC
CAU
GWM
NEI
CCM
NHC